Ankur Teredesai

KenSci, Inc. develops risk prediction platform for the healthcare industry. It offers care variation, chronic kidney disease, sepsis, and end of life predictions. The firm also provides risk of readmission solutions. The company was founded by David Hazel, Samir Manjure, and Ankur Teredesai in November 2015 and is headquartered in Seattle, WA.

CUEZEN INC. is an American US-based company that offers an AI-based personalization engine for health. The private company leverages advanced algorithms and data analytics to provide personalized health recommendations, treatment plans, and interventions. The company's cloud-native, AI-based personalization engine guides patients on individual pathways, driving adherence to prescribed treatment regimens. Cuezen's generative AI engine sends personalized, evidence-based cues driving healthy behavior change in patients and improving healthcare outcomes for organizations. The company integrates data from device sensors, self-reported outcomes and measures, and clinical records to enable personalized assessment of care for members. Cuezen helps healthcare providers engage their members through differentiated offerings in a crowded DTX marketplace, attracting patient enrollment with personalized benefit offerings based on individual needs.